OTC : CHSYF
$0.0 (0.11%)
OTC
Kong Lam
Drug Manufacturers - Specialty & Generic
Healthcare
CHSYF
6415
HK
USD
0.04
6.33
5.78
1.84
0.44
$8B
3.18
1.49
106.99
0.10
$0.6
$1.45B
18.13%
25.61%
8.65%
7.75%
17.59
-2.32
-2.32
4/5
0 Analysts
%
| Name | Title |
|---|---|
| Fei Jiang | Chief Investment Officer of Greater China |
| James Patrick Stearns | Chief Investment Officer of Europe & America |
| Sanyan Wu | Director of Legal Department & Company Secretary |
| Yanling Chen | Chief Financial Officer, Vice President & Executive Director |
| Kong Lam | Founder, Chairman, Chief Executive Officer & President |
| Lieyi Ma | General Manager of the Operations & Management Center of the Group |
| Liu Yue | Director of Investor Relations |
| Huaizheng Peng | Chief Business Officer |
No votes yet today — be the first to share your view!
About China Medical System Holdings Limited (OTC:CHSYF) Stock
China Medical System Holdings Limited functions as an investment holding enterprise with a primary focus on the pharmaceutical sector within the People's Republic of China. The company's core activities involve the development, marketing, and distribution of a comprehensive range of pharmaceutical products. Its diverse portfolio addresses a wide array of medical conditions, offering treatments for cardiovascular issues (such as Plendil for hypertension and Imdur for heart disease), mental health disorders (including Deanxit for depression and anxiety), and various gastrointestinal ailments (like Ursofalk for gallstones and Salofalk for inflammatory bowel conditions). Furthermore, its therapeutic range extends to solutions for acute heart failure (XinHuoSu), numerous infections (e.g., DanSh ... enTong capsules), respiratory illnesses (YiNuoShu), liver cancer (Ganfule capsules), osteoporosis (Elcatonin injection), and dermatological fungal conditions (Lamisil tablets), among many others. Beyond its principal pharmaceutical operations, the company also maintains interests in agriculture and livestock. Established in 1995, China Medical System Holdings Limited is based in North Point, Hong Kong, and operates as a subsidiary of Treasure Sea Limited.
Frequently Asked Questions
What is the current China Medical System Holdings Limited (CHSYF) stock price?
China Medical System Holdings Limited(OTC:CHSYF) stock price is $1.57 in the last trading session. During the trading session, CHSYF stock reached the peak price of $1.57 while $0.9307 was the lowest point it dropped to. The percentage change in CHSYF stock occurred in the recent session was 0.11% while the dollar amount for the price change in CHSYF stock was $0.0.
CHSYF's industry and sector of operation?
The OTC listed CHSYF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
Who are the executives of CHSYF?
Fei Jiang
| Chief Investment Officer of Greater China
James Patrick Stearns
| Chief Investment Officer of Europe & America
Sanyan Wu
| Director of Legal Department & Company Secretary
Yanling Chen
| Chief Financial Officer, Vice President & Executive Director
Kong Lam
| Founder, Chairman, Chief Executive Officer & President
How many employees does CHSYF have?
Number of CHSYF employees currently stands at 6415. CHSYF operates from Island Place Tower, North Point, GD None, HK.
Link for CHSYF official website?
Official Website of CHSYF is: https://www.cms.net.cn
How do I contact CHSYF?
CHSYF could be contacted at phone #852 2369 7678 and can also be accessed through its website. CHSYF operates from Island Place Tower, North Point, GD None, HK.
How many shares of CHSYF are traded daily?
The average number of CHSYF shares traded daily for last 3 months was 19.
What is the market cap of CHSYF currently?
The market value of CHSYF currently stands at $3.8B with its latest stock price at $1.57